NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

MCL is a rare and aggressive type of non-Hodgkin lymphoma. It is considered incurable with current treatments and often comes back. Many people are diagnosed when the disease is at an advanced stage ...

Few country songs have been as transformative for two legendary artists’ careers as “Crazy”. Penned by Willie Nelson and made definitive by Patsy Cline, this 1960s staple saved both of their careers ...

Emmerdale has confirmed the return of Patsy Kensit as Sadie King. It was recently reported that the star, who appeared on EastEnders a few years ago, would be back as the villainous character after 20 ...

You don’t mess with the classics. In a chaotic world that ceaselessly hurls distractions at us through the digital rectangular devices in our pockets, it’s often the slow, frill-less, anachronistic ...

Eli Lilly has chalked up another victory in the chronic lymphocytic leukemia (CLL) space, as its BTK inhibitor Jaypirca delivered its fourth positive phase 3 readout in the blood cancer. Monday, Lilly ...

A big name is rumoured to be making a return to Emmerdale after two decades away. Patsy Kensit is reportedly coming back to the Dales as villain Sadie King, who was last seen leaving the village in ...

CLL17 finds fixed-duration venetoclax regimens match continuous ibrutinib at 3 years, boosting confidence in personalized frontline CLL choices. Results from the phase 3 CLL17 trial (NCT04608318) are ...

Retreatment with venetoclax and rituximab in CLL patients achieved 100% response rates and prolonged progression-free survival. Median progression-free survival was 9.5 years from initial treatment ...